Akido raises $60 million in Series B funding to enhance ScopeAI, their innovative health AI solution. This investment will support Akido's mission to democratize high-quality healthcare worldwide.
May 15, 2025•7 months ago
Amount Raised
$60 Million
Round Type
series b
Description
Akido has successfully raised $60 million in Series B funding to further develop ScopeAI, a revolutionary health AI product. This technology addresses the global physician shortage by empowering healthcare providers. With the additional funding, Akido aims to increase access to care and improve service quality. The company is committed to ensuring timely healthcare is available to all, regardless of financial means or geography.
Funding Insights
Based on industry dataTech investment trends
83% of B2B companies plan digital investments, with 79% prioritizing customer experience tech